R

Revolution Medicines
D

RVMD

152.480
USD
5.47
(3.72%)
مغلق
حجم التداول
556,307
الربح لكل سهم
-8
العائد الربحي
-
P/E
-26
حجم السوق
30,217,479,575
أصول ذات صلة المقالات
المزيد

العنوان: Revolution Medicines

القطاع: Healthcare
الصناعة: Biotechnology
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.